These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34866584)

  • 1. One-year outcomes of novel BioMime Morph tapered stent in long and multiple coronary artery lesions.
    Sharma YP; Uppal L; Panda P; Mohanty S; Kasinadhuni G; Krishnappa D; Mehrotra S; Gupta A; Prasad K; Santosh K; Bootla D; Ghosh S
    Anatol J Cardiol; 2021 Dec; 25(12):896-901. PubMed ID: 34866584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and Outcomes of Left Main to Branch Vessel PCI with Novel Tapered Coronary Stent in a Tertiary Care Centre: A Real World Experience.
    Raghu TR; Raj VAS; Kharge J; Setty HSN; Patil RS; Manjunath CN
    Cardiovasc Hematol Disord Drug Targets; 2021; 21(2):128-135. PubMed ID: 34387173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial.
    Dani S; Costa RA; Joshi H; Shah J; Pandya R; Virmani R; Sheiban I; Bhatt S; Abizaid A
    EuroIntervention; 2013 Aug; 9(4):493-500. PubMed ID: 23965355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Report of Successful Procedural, Clinical, and Angiographic Outcomes with a Tapered Stent of a Patient in Naturally Tapered Coronary Vessel.
    Premchand RK; Kumar YS
    J Clin Diagn Res; 2017 Jan; 11(1):OD06-OD07. PubMed ID: 28273994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of everolimus-eluting stent implantation in patients with small coronary arteries (≤2.5 mm): outcomes of 3-year clinical follow-up.
    Yano H; Horinaka S; Ishikawa M; Ishimitsu T
    Heart Vessels; 2017 Jul; 32(7):796-803. PubMed ID: 28025695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Safety and Performance of BioMime™ Morph Sirolimus-Eluting Coronary Stent System for Very Long Coronary Lesions.
    Patted SV
    Cardiol Res; 2024 Jun; 15(3):169-178. PubMed ID: 38994223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year clinical outcomes of patients with overlapping second-generation drug-eluting stents for treatment of long coronary artery lesions: comparison of everolimus-eluting stents with resolute zotarolimus-eluting stents.
    Li XT; Sun H; Zhang DP; Xu L; Ni ZH; Xia K; Liu Y; Chi YH; He JF; Li WM; Wang HS; Wang LF; Yang XC
    Coron Artery Dis; 2014 Aug; 25(5):405-11. PubMed ID: 24584031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial.
    Kandzari DE; Koolen JJ; Doros G; Garcia-Garcia HM; Bennett J; Roguin A; Gharib EG; Cutlip DE; Waksman R;
    JACC Cardiovasc Interv; 2020 Jun; 13(11):1343-1353. PubMed ID: 32499026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of Novel Long-Tapered Sirolimus-Eluting Coronary Stent System in Real-World Patients With Long Diffused
    Patted SV; Jain RK; Jiwani PA; Suryavanshi S; Raghu TR; Raveesh H; Rajalakshmi S; Thakkar AS; Turiya PK; Desai PJ; Patted AS; Sharma KH
    Cardiol Res; 2018 Dec; 9(6):350-357. PubMed ID: 30627285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial.
    Abizaid A; Kedev S; Kedhi E; Talwar S; Erglis A; Hlinomaz O; Masotti M; Fath-Ordoubadi F; Lemos PA; Milewski K; Botelho R; Costa R; Bangalore S
    EuroIntervention; 2018 Dec; 14(11):e1207-e1214. PubMed ID: 30222120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with 12-month follow-up in patients after implantation of a novel long-tapered sirolimus drug-eluting stent.
    Podolec J; Skubera M; Niewiara Ł; Podolec M; Pieniążek P; Bartuś K; Żmudka K; Legutko J
    Postepy Kardiol Interwencyjnej; 2019; 15(1):46-51. PubMed ID: 31043984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial.
    Raungaard B; Christiansen EH; Bøtker HE; Hansen HS; Ravkilde J; Thuesen L; Aarøe J; Villadsen AB; Terkelsen CJ; Krusell LR; Maeng M; Kristensen SD; Veien KT; Hansen KN; Junker A; Madsen M; Andersen SL; Jensen SE; Jensen LO;
    JACC Cardiovasc Interv; 2017 Feb; 10(3):255-264. PubMed ID: 28109874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE Trial.
    Zbinden R; Piccolo R; Heg D; Roffi M; Kurz DJ; Muller O; Vuilliomenet A; Cook S; Weilenmann D; Kaiser C; Jamshidi P; Franzone A; Eberli F; Jüni P; Windecker S; Pilgrim T
    J Am Heart Assoc; 2016 Mar; 5(3):e003255. PubMed ID: 26979080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Assessment of Thin-Strut BioMime Coronary Stent System in Real-World Population at Single-Center: A Retrospective Observational Study.
    Meennahalli Palleda G; Gupta M; Bansal A; Batra V; Tyagi S; Kunal S
    Cardiol Res; 2023 Oct; 14(5):360-369. PubMed ID: 37936627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Clinical Outcomes Following Single versus Multivessel Percutaneous Coronary Intervention Using Biodegradable Polymer Coated Sirolimus-Eluting Stent in an All-comers Patient Population.
    Chandwani P; Verma P; Saxena S; Ramachandran PK; Abhyankar A; Sandhu MS; Parikh N; Bhupali A; Jain S; Prajapati J
    Cardiovasc Hematol Agents Med Chem; 2016; 14(1):39-48. PubMed ID: 26585397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of BioMime Morph stent in treating left main triple vessel disease: a case report.
    Sharma YP; Santosh K; Panda P; Prasad K; Uppal L; Y S S; Pruthvi CR; Dinakar B
    Egypt Heart J; 2020 Aug; 72(1):47. PubMed ID: 32754802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the relation between IVUS measurements and clinical outcome in elderly patients after sirolimus-eluting stent implantation for de novo coronary lesions.
    Du R; Zhang RY; Zhang Q; Shi YH; Hu J; Yang ZK; Ding FH; Zhang JS; Shen WF
    Int J Cardiovasc Imaging; 2012 Oct; 28(7):1653-62. PubMed ID: 22222382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year outcomes of a BioMime™ Sirolimus-Eluting Coronary Stent System with a biodegradable polymer in all-comers coronary artery disease patients: The meriT-3 study.
    Jain RK; Chakravarthi P; Shetty R; Ramchandra P; Polavarapu RS; Wander GS; Mohan B; Banker DN; Dharmadhikari A; Bansal SS; Jain N; Solanki D; Dhakaan J; Sharma VP; Mohanan PP; Ashokan PK; Manjunath BV; Hiregoudar N; Patil C; Balakrishnan N
    Indian Heart J; 2016; 68(5):599-603. PubMed ID: 27773396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.